Semi-Annual Consolidated Statement Of Income

D.Western Therapeutics Institute, Inc. - Filing #7313030

Concept 2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
Semi-annual consolidated statement of income
Statement of income
Net sales
223,522,000 JPY
187,710,000 JPY
Cost of sales
18,531,000 JPY
14,696,000 JPY
Gross profit (loss)
204,990,000 JPY
173,014,000 JPY
Ordinary profit (loss)
-459,287,000 JPY
-254,590,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
53,539,000 JPY
51,774,000 JPY
Selling, general and administrative expenses
654,835,000 JPY
431,366,000 JPY
Extraordinary losses
60,612,000 JPY
JPY
Profit (loss) before income taxes
-519,900,000 JPY
-254,590,000 JPY
Operating profit (loss)
-449,844,000 JPY
-258,352,000 JPY
Income taxes - current
797,000 JPY
797,000 JPY
Non-operating income
Interest income
4,000 JPY
6,000 JPY
Non-operating income
5,751,000 JPY
6,292,000 JPY
Non-operating expenses
Interest expenses
2,103,000 JPY
1,225,000 JPY
Non-operating expenses
15,194,000 JPY
2,530,000 JPY
Income taxes
797,000 JPY
797,000 JPY
Profit (loss)
-520,697,000 JPY
-255,387,000 JPY
Profit (loss) attributable to non-controlling interests
JPY
-7,403,000 JPY
Extraordinary losses
Profit (loss) attributable to owners of parent
-520,697,000 JPY
-247,983,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
2,000 JPY
191,000 JPY
Other comprehensive income
2,000 JPY
191,000 JPY
Comprehensive income
-520,695,000 JPY
-255,196,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-520,695,000 JPY
-247,792,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
-7,403,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.